Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK
2006

Evaluating Injectable Opioid Treatment for Heroin Dependence

Sample size: 150 publication Evidence: low

Author Information

Author(s): Lintzeris Nicholas, Strang John, Metrebian Nicola, Byford Sarah, Hallam Christopher, Lee Sally, Zador Deborah

Primary Institution: Institute of Psychiatry, King's College London

Hypothesis

Should patients not responding to oral methadone treatment be treated with injectable methadone or heroin?

Conclusion

The study aims to determine if injectable opioids are more effective than optimized oral methadone for patients who continue to inject heroin.

Supporting Evidence

  • Injectable opioid treatment has been part of the British system for decades but is declining.
  • Up to 50% of patients drop out of maintenance treatment within 12 months.
  • Only one previous RCT of injectable methadone has been conducted in the UK.

Takeaway

This study is trying to find out if giving people heroin or methadone through a needle helps them stop using heroin better than just taking methadone by mouth.

Methodology

A multisite, prospective open-label randomized controlled trial comparing three treatment conditions over 6 months.

Potential Biases

Potential bias due to the open-label design where both participants and researchers know the treatment allocation.

Limitations

Limited evidence supporting injectable opioid treatment and concerns regarding medication diversion.

Participant Demographics

Patients aged 18-65 with a history of heroin dependence and currently in oral methadone treatment.

Digital Object Identifier (DOI)

10.1186/1477-7517-3-28

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication